Literature DB >> 36057006

The interplay between HLA-B and NLRP3 polymorphisms may be associated with the genetic susceptibility of gout.

Javier Fernández-Torres1,2, Gabriela Angélica Martínez-Nava3, Karina Martínez-Flores1, Roberto Sánchez-Sánchez4, Luis J Jara5, Yessica Zamudio-Cuevas6.   

Abstract

BACKGROUND: HLA and NLRP3 play an important role in the development of various autoimmune and autoinflammatory diseases. Gout is an autoinflammatory disease associated with multiple genetic and environmental factors. The objective of the present study was to evaluate the interaction and association between genetic polymorphisms of HLA-B and the NLRP3 gene in Mexican patients with gout. METHODS AND
RESULTS: Eighty-one patients with gout were included and compared with 95 healthy subjects. The polymorphisms rs4349859, rs116488202, rs2734583 and rs3099844 (within the HLA-B region) and rs3806268 and rs10754558 of the NLRP3 gene were genotyped using TaqMan probes in a Rotor-Gene device. The interactions were determined using the multifactorial dimensionality reduction (MDR) method, while the associations were determined through logistic regression models. The MDR analysis revealed significant interactions between the rs116488202 and rs10754558 polymorphisms with an entropy value of 4.31% (p < 0.0001). Significant risk associations were observed with rs4349859 and rs116488202 polymorphisms (p < 0.01); however, no significant associations were observed with the polymorphisms of the NLRP3 gene.
CONCLUSIONS: The results suggest that HLA-B polymorphisms and their interaction with NLRP3 may contribute to the genetic susceptibility of gout.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Epistasis; Genetic polymorphisms; Gout; HLA-B; NLRP3

Year:  2022        PMID: 36057006     DOI: 10.1007/s11033-022-07895-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  40 in total

Review 1.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

Review 2.  Inflammation in gout: mechanisms and therapeutic targets.

Authors:  Alexander K So; Fabio Martinon
Journal:  Nat Rev Rheumatol       Date:  2017-09-28       Impact factor: 20.543

3.  Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study.

Authors:  Qiong Yang; Chao-Yu Guo; L Adrienne Cupples; Daniel Levy; Peter W F Wilson; Caroline S Fox
Journal:  Metabolism       Date:  2005-11       Impact factor: 8.694

Review 4.  Genetics of gout.

Authors:  Hyon K Choi; Yanyan Zhu; David B Mount
Journal:  Curr Opin Rheumatol       Date:  2010-03       Impact factor: 5.006

5.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

6.  Innate immunity functional gene polymorphisms and gout susceptibility.

Authors:  Yu-Feng Qing; Quan-Bo Zhang; Jing-Guo Zhou
Journal:  Gene       Date:  2013-04-29       Impact factor: 3.688

Review 7.  The genetics of hyperuricaemia and gout.

Authors:  Anthony M Reginato; David B Mount; Irene Yang; Hyon K Choi
Journal:  Nat Rev Rheumatol       Date:  2012-09-04       Impact factor: 20.543

8.  Synovial fluid analysis for the enhanced clinical diagnosis of crystal arthropathies in a tertiary care institution.

Authors:  Yessica Zamudio-Cuevas; Gabriela Angélica Martínez-Nava; Karina Martínez-Flores; Lucio Ventura-Ríos; Janitzia Vazquez-Mellado; Pedro Rodríguez-Henríquez; Carlos Pineda; Rafael Franco-Cendejas; Carlos Alberto Lozada-Pérez; Javier Fernández-Torres
Journal:  Clin Rheumatol       Date:  2021-02-17       Impact factor: 2.980

Review 9.  An update on the genetic architecture of hyperuricemia and gout.

Authors:  Tony R Merriman
Journal:  Arthritis Res Ther       Date:  2015-04-10       Impact factor: 5.156

Review 10.  Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.

Authors:  Ran Wu; Yi-Ju Cheng; Li-Li Zhu; Lei Yu; Xue-Ke Zhao; Min Jia; Chang-Hui Wen; Xing-Zhen Long; Ting Tang; Ai-Juan He; Yi-Yan Zeng; Zun-Feng Ma; Zhi Zheng; Mu-Zi Ni; Gong-Jing Cai
Journal:  Oncotarget       Date:  2016-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.